癌痛规范化诊疗质控项目实施以来我院镇痛用麻醉药品使用情况分析与比较

ANALYSIS AND COMPARISON OF NARCOTIC DRUG USE OF PEKING UNIVERSITY THIRD HOSPITAL SINCE GOOD PAIN MANAGEMENT DIAGNOSIS AND THERAPY PROGRAM

目的:针对卫计委"癌症疼痛规范化诊疗质控项目"实施前、后的麻醉性镇痛药品使用情况进行分析和比较,为合理用药提供指导。方法:提取我院2014年7月-2015年6月的门诊及肿瘤住院患者麻醉药品用药信息并比较分析。结果:与项目实施前相比,2015年上半年镇痛用麻醉药品的数量、金额、DDDs和DDDc稳步增长。金额由高到低排序前三名依次为(门诊/住院):盐酸羟考酮缓释片(915031.0元/107866.5元),芬太尼透皮贴(190259.0元/139490.6元),硫酸吗啡缓释片(23401.8元/3457.7元)。哌替啶使用量显著减少,住院患者的DDDc值降低,提示镇痛用药选择优化。结论:质控项目实施以来我院麻醉药物使用量呈增长趋势,各药使用基本合理。质控项目促进了我院疼痛诊疗合理用药。

Objective： The aim of this investigation is to compare and analyze the narcotic drug use of Peking University Third Hospital before and after the ＂Good Pain Management（ GPM） diagnosis and therapy program＂and to provide guidance to rational use of narcotics for cancer patients with pain.Methods： Analyzing the consumption amount,cost,Defined Daily Dose（ DDDs） and Defined Daily Dose cost（ DDDc） of narcotics from July 2014 to June 2015.Results： The total narcotic consumption was increased after the GPM program,while the inpatient DDDc was decreased,indicating the burden of drug expenses was reduced. The top three narcotics were oxycodone prolonged- release tablets,fentanyl transdermal system and morphine sulfate sustained- release tablets,accounting for over 98% in cost.Conclusion： The inpatient narcotics use was generally rational during the first half of 2015. The GPM program contributes to the rational use of narcortic in our hospital.